v3.26.1
SCHEDULE OF COMMON STOCK OUTSTANDING (Details) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Number of Options Outstanding and Vested, Outstanding, Balance 70,667 40,667 40,667  
Weighted Average Exercise Price, Outstanding, Balance $ 0.1217 $ 0.2041 $ 0.2041  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term 4 years 3 months 3 days 4 years 10 months 17 days 4 years 1 month 6 days 3 years 5 months 8 days
Aggregated Intrinsic Value, Balance $ 290,321 $ 249,122 $ 249,122  
Number of Options Outstanding and Vested, Issued 454,996 [1] 439,996 [2]    
Weighted Average Exercise Price, Issued $ 0.0075 [1] $ 0.0077 [2]    
Number of Options Outstanding and Vested, Exercised [1] (2,500)    
Weighted Average Exercise Price, Exercised [1] $ 0.0075    
Number of Options Outstanding and Vested, Forfeited [1] (7,500)    
Weighted Average Exercise Price, Forfeited [1] $ 0.0075    
Number of Options Outstanding and Vested, Outstanding, Balance 515,663 480,663 70,667 40,667
Weighted Average Exercise Price, Outstanding, Balance $ 0.0232 $ 0.0243 $ 0.1217 $ 0.2041
Aggregated Intrinsic Value, Balance $ 1,890,859 $ 1,804,206 $ 290,321 $ 249,122
Warrant [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Number of Warrants Outstanding and Vested, Balance 75,000      
Weighted Average Exercise Price, Outstanding and vested, Balance $ 8.1250      
Weighted Average Contractual Life (Years) Balance     2 years 29 days  
Aggregated Intrinsic Value, Balance      
Number of Warrants Outstanding and Vested, Warrants Issued [3]      
Weighted Average Exercise Price, Warrants Issued [3]      
Number of Warrants Outstanding and Vested, Balance 75,000   75,000  
Weighted Average Exercise Price, Outstanding and vested, Balance $ 8.1250   $ 8.1250  
Weighted Average Contractual Life (Years) Balance 6 months 29 days      
Aggregated Intrinsic Value, Balance    
[1] In the six months ended June 30, 2026, 454,996 common stock options were issued with a grant date fair value of $1,993,182.
[2] In the six months ended June 30, 2025, 439,966 common stock options were issued with a grant date fair value of $3,066,772.
[3] In the six months ended June 30, 2026, 135,540 RSUs were granted to officers and consultants of the Company, with a total grant date fair value of $600,300 as measured at an average $4.43/share trailing to the date the RSU all granted with time-based vesting of four years.